Literature DB >> 18946069

Targeting EGFR in colorectal cancer.

Wells A Messersmith, Dennis J Ahnen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18946069     DOI： 10.1056/NEJMe0806778

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  48 in total

1.  Cost-effectiveness analysis of KRAS testing and cetuximab as last-line therapy for colorectal cancer.

Authors:  Takeru Shiroiwa; Yoshiharu Motoo; Kiichiro Tsutani
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

2.  Case records of the Massachusetts General Hospital. Case 19-2010. A 35-year-old man with adenocarcinoma of the cecum.

Authors:  David P Ryan; Jeffrey A Engelman; Cristina R Ferrone; Dushyant V Sahani; Mikhail Lisovsky
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

Review 3.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

4.  Use of archived specimens in evaluation of prognostic and predictive biomarkers.

Authors:  Richard M Simon; Soonmyung Paik; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2009-10-08       Impact factor: 13.506

5.  MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.

Authors:  Yunxiang Chen; Rui Li; Minhong Pan; Zhumei Shi; Wei Yan; Ning Liu; Yongping You; Junxia Zhang; Xiefeng Wang
Journal:  J Neurooncol       Date:  2017-05-13       Impact factor: 4.130

Review 6.  Building a personalized medicine infrastructure at a major cancer center.

Authors:  Funda Meric-Bernstam; Carol Farhangfar; John Mendelsohn; Gordon B Mills
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

Review 7.  Harnessing Tumor Evolution to Circumvent Resistance.

Authors:  Katherine L Pogrebniak; Christina Curtis
Journal:  Trends Genet       Date:  2018-06-11       Impact factor: 11.639

8.  Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.

Authors:  Vassiliki Kotoula; Elpida Charalambous; Bart Biesmans; Andigoni Malousi; Eleni Vrettou; George Fountzilas; George Karkavelas
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

9.  Tumor biology and cancer therapy - an evolving relationship.

Authors:  Thomas Seufferlein; Johann Ahn; Denis Krndija; Ulrike Lother; Guido Adler; Götz von Wichert
Journal:  Cell Commun Signal       Date:  2009-08-13       Impact factor: 5.712

10.  Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.

Authors:  J Souglakos; J Philips; R Wang; S Marwah; M Silver; M Tzardi; J Silver; S Ogino; S Hooshmand; E Kwak; E Freed; J A Meyerhardt; Z Saridaki; V Georgoulias; D Finkelstein; C S Fuchs; M H Kulke; R A Shivdasani
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.